CAS: 2163056-91-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | 2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide REF: AN-AG01K8N6CAS: 2163056-91-3 | 99+% | To inquire | Mon 03 Jun 24 |
 | BI-1347 REF: TM-T5405CAS: 2163056-91-3 | 99.43% | 40.00 €~1,328.00 € | Mon 10 Jun 24 |
 | BI-1347 REF: 3D-NLD05691CAS: 2163056-91-3 | Min. 95% | To inquire | Mon 15 Jul 24 |
2-(4-(4-(Isoquinolin-4-yl)phenyl)-1H-pyrazol-1-yl)-N,N-dimethylacetamide
CAS:2163056-91-3
Formula:
C22H20N4O
Purity:
99+%
Color and Shape:
Solid
Molecular weight:
356.4204
Ref: AN-AG01K8N6
| 5mg | 147.00 € | |
| 10mg | 232.00 € | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 3 Jun 2024
BI-1347
CAS:2163056-91-3
BI-1347 is a potent, selective inhibitor of CDK8/cyclinC (IC50: 1 nM). It shows tumor growth …
Formula:
C22H20N4O
Purity:
99.43%
Color and Shape:
Solid
Molecular weight:
356.42
Ref: TM-T5405
| 1mg | 40.00 € | |
| 5mg | 86.00 € | |
| 10mg | 123.00 € | |
| 25mg | 235.00 € | |
| 50mg | 430.00 € | |
| 100mg | 634.00 € | |
| 500mg | 1,328.00 € | |
| 1ml*10 (DMSO) | 96.00 € |
Estimated delivery in United States, on Monday 10 Jun 2024
BI-1347
CAS:2163056-91-3
BI-1347 is a small molecule that has been shown to be effective in the treatment …
Formula:
C22H20N4O
Purity:
Min. 95%
Molecular weight:
356.42 g/mol
Ref: 3D-NLD05691
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire | |
| 100mg | To inquire |
Estimated delivery in United States, on Monday 15 Jul 2024
